Healthcare Analysts discuss what wet AMD patients want (relevant companies CLSD, OCUL, EYPT, REGN, OPT, OTLK, ADVM, FDMT, RGNX, ABBV) on an Analyst/Industry conference call to be held on September 18.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLSD:
- Clearside completes final participant visit in CLS-AX trial for wet AMD
- Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
- Clearside Biomedical management to meet with Oppenheimer
- Clearside Biomedical initiated with a Buy at Chardan
- Clearside Biomedical reports Q2 EPS (10c), consensus (13c)